Doxorubicin-loaded drug-eluting beads (DC Bead(R)) for use in transarterial chemoembolization: A stability assessment.

Hecq, Jean-Daniel;Lewis, Andrew L;Vanbeckbergen, Danielle;Athanosopoulos, Alexandre;Chung, Ting;et.al.
(2013) Journal of Oncology Pharmacy Practice — Vol. 19, n° 1, p. 65-74 (2013)

Files

HecqJDetalJOncolPharmPractice2013.pdf
  • Restricted Access
  • Adobe PDF
  • 656.61 KB
Request a copy

Details

Authors
  • Hecq, Jean-DanielUCLouvain
    Author
  • Lewis, Andrew L
    Author
  • Vanbeckbergen, Danielle
    Author
  • Athanosopoulos, Alexandre
    Author
  • Galanti, LaurenceUCLouvain
    Author
  • Jamart, JacquesUCLouvain
    Author
  • Chung, Ting
    Author
Show more
Abstract
Doxorubicin-loaded DC Bead® are shown to have adequate physicochemical stability over a period of 14 days when stored in syringes or vials under refrigerated conditions for up to 14 days. The admixtures of doxorubicin-loaded beads with contrast medium are stable for up to 7 days under refrigerated conditions.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hecq, J.-D., Lewis, A. L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., & Chung, T. (2013). Doxorubicin-loaded drug-eluting beads (DC Bead(R)) for use in transarterial chemoembolization: A stability assessment. Journal of Oncology Pharmacy Practice, 19(1), 65-74. https://doi.org/10.1177/1078155212452765 (Original work published 2013)